Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

faricimab ophthalmic

faricimab ophthalmic
Brand names: Vabysmo
Form Strength
SOLUTION, INTRAVITREAL 120 mg/mL


Additional Information:

 Faricimab (Vabysmo) is Formulary, Restricted to use by Devers, for adult patients with exudative age-related macular degeneration or macular edema due to diabetes mellitus who have failed bevacizumab (Avastin).


Last updated: Jun. 10, 2022







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.